Zoltan Ivics

Head of Department

Fraunhofer Institute for Cell Therapy and Immunology

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Tissue Engineering Tissue Engineering professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Zoltan Ivics is the Head of Department at the Fraunhofer Institute for Cell Therapy and Immunology in Germany. His research areas encompass gene editing, transposon biology, and non-viral genome engineering, as evidenced by his recent publications on Sleeping Beauty transposase and its applications in immunotherapy. He has contributed to significant advancements in understanding the mechanisms of CRISPR technologies and their therapeutic potential.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (7)

Stefan Zielen

Professor for Cystic fibrosis, allergy and pneumology

Educational Research Institute

GERMANY

View details

Esther Grueso

Profesor investigador

Universidad Francisco de Vitoria

SPAIN

View details

Sandra Johnen

University Hospital RWTH Aachen

GERMANY

View details

Anne Balkema-Buschmann

Deputy head, Senior Scientist

Friedrich-Loeffler-Institut

GERMANY

View details

Ulrike Koehl

Professor and Director, Institute for Clinical Immunology

University Hospital Leipzig

GERMANY

View details

Ralf Schubert

University Hospital

GERMANY

View details

Johanna Olweus

Professor

University of Oslo

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zoltan Ivics

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

DNA binding and transposition activity of the Sleeping Beauty transposase: role of structural stability of the primary DNA-binding domain

An LNP-CRISPR gene editing drug demonstrates efficacy and safety in patients with hereditary angioedema following in vivo administration

Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs

Non-viral vectors for chimeric antigen receptor immunotherapy

A novel hyperactive variant of the Sleeping Beauty transposase facilitates non-viral genome engineering

The best of both worlds: AAV-mediated gene transfer empowered by LNP delivery of Sleeping Beauty transposase for durable transgene expression in vivo

Enhanced Biosafety of the Sleeping Beauty Transposon System by Using mRNA as Source of Transposase to Efficiently and Stably Transfect Retinal Pigment Epithelial Cells

CRISISS: A Novel, Transcriptionally and Post-Translationally Inducible CRISPR/Cas9-Based Cellular Suicide Switch

In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA

Generation of four gene-edited human induced pluripotent stem cell lines with mutations in the ATM gene to model Ataxia-Telangiectasia

Sleeping Beauty Transposon Insertions into Nucleolar DNA by an Engineered Transposase Localized in the Nucleolus

HMGXB4 Targets <i>Sleeping Beauty</i> Transposition to Germinal Stem Cells

Passer, a highly active transposon from a fish genome, as a potential new robust genetic manipulation tool

Horizontal Transfer and Evolutionary Profiles of Two Tc1/DD34E Transposons (ZB and SB) in Vertebrates

Collaborators (7)

Stefan Zielen

Esther Grueso

Sandra Johnen

Anne Balkema-Buschmann

Ulrike Koehl

Ralf Schubert

Johanna Olweus

Make your next move.